Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 844 across all filing types
Latest filing 2018-05-20 Regulatory Filings
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Clarification to Announcement 1 page 444.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX/Media Announcement dated 21 May 2018, titled 'Clarifying Statement'. It provides additional information related to a previous announcement about Bioxyne's expansion and mentions shareholder approval under ASX Listing Rule 7.1. The content is brief (1474 characters) and does not contain financial statements, detailed financial data, or comprehensive report content. It is an update or clarification related to company activities and regulatory compliance rather than a full report or detailed financial disclosure. Therefore, it fits best as a Regulatory Filing (RNS), which is a general category for regulatory announcements and compliance-related disclosures that do not fit other specific categories.
2018-05-20 English
Initial Director's Interest Notice 2 pages 291.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the appointment date of a director and discloses the director's relevant interests in securities and contracts, all of which are nil. This is a report of personal share transactions or interests by a company director. The document length is short and it is a formal notification of director's interests, which aligns with the definition of Director's Dealing filings. Therefore, the document is classified as a Director's Dealing (DIRS) filing.
2018-05-03 English
Appointment of Non-Executive Director 1 page 571.2K
Board/Management Information Classification · 100% confidence The document is an ASX announcement dated 1 May 2018 regarding the appointment of Mr. Peter Charles Hughes-Hallett as a Non-Executive Director of Bioxyne Limited. The content focuses solely on the appointment and biography of a new board member. There is no financial data, no mention of reports, no voting results, no legal proceedings, or other types of filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short (2001 characters), consistent with a management announcement rather than a full report or other filing type.
2018-04-30 English
Securities Trading Policy - Updated 14 pages 287.6KB
Governance Information Classification · 95% confidence The document is titled 'SECURITIES TRADING POLICY' and outlines rules and procedures for Key Management Personnel (KMP) and employees regarding trading in company securities. It discusses insider trading, closed periods, clearance requirements, and notification of trades. There is no financial data, earnings information, or report content. It is a governance-related policy document concerning internal rules on securities trading and compliance with ASX Listing Rules and Corporations Act. This fits the definition of Governance Information (CGR) as it details the company's internal rules and governance practices related to securities trading by insiders.
2018-04-29 English
Quarterly Activities and Quarterly Cash Flow Reports 8 pages 740.9KB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'QUARTERLY REPORT FOR THE PERIOD ENDED 31 MARCH 2018' and contains detailed financial information including revenue, cash flows from operating, investing, and financing activities, and a compliance statement. It also references the Appendix 4C Quarterly report format under ASX Listing Rule 4.7B, which is a standard quarterly financial report for Australian listed entities. The document is approximately 12,869 characters long, indicating it is a substantive report rather than a brief announcement. The content includes actual financial data and analysis for a quarter, consistent with an Interim / Quarterly Report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2018
2018-04-26 English
Investor Update 30 pages 5.0MB
Investor Presentation Classification · 95% confidence The document is titled 'Investor update' and is dated March 2018. It contains detailed information about the company's business strategy, product lines, market positioning, leadership team, share price performance, and comparable companies. The content is presented in a slide/presentation format with disclaimers, forward-looking statements, and contact information. There are no detailed financial statements, audit opinions, or regulatory certifications included. The document is not a formal annual or interim report, nor is it a transcript of a call or a legal proceeding. It is a comprehensive presentation aimed at investors, focusing on financials, strategy, and market position. Therefore, the document best fits the category of an Investor Presentation (IP). The document length (over 14,000 characters) supports that it is a full presentation rather than a brief announcement or summary.
2018-03-18 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.